MediWound (MDWD) Competitors

MediWound (NASDAQ:MDWD) and CorMedix (NASDAQ:CRMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking.

Which has more volatility & risk, MDWD or CRMD?

MediWound has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, CorMedix has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Does the MarketBeat Community believe in MDWD or CRMD?

MediWound received 363 more outperform votes than CorMedix when rated by MarketBeat users. However, 79.55% of users gave CorMedix an outperform vote while only 62.28% of users gave MediWound an outperform vote.

Company	Underperform	Outperform
MediWound	Outperform Votes 398 62.28%	Underperform Votes 241 37.72%
CorMedix	Outperform Votes 35 79.55%	Underperform Votes 9 20.45%

Which has preferable earnings & valuation, MDWD or CRMD?

MediWound has higher earnings, but lower revenue than CorMedix. MediWound is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$20.22M	11.15	-$6.72M	-$3.07	-6.80
CorMedix	$82.55M	10.53	-$46.34M	$0.22	58.27

Do insiders & institutionals have more ownership in MDWD or CRMD?

46.8% of MediWound shares are held by institutional investors. Comparatively, 34.2% of CorMedix shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 5.2% of CorMedix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the media refer more to MDWD or CRMD?

In the previous week, CorMedix had 4 more articles in the media than MediWound. MarketBeat recorded 7 mentions for CorMedix and 3 mentions for MediWound. CorMedix's average media sentiment score of 1.28 beat MediWound's score of 0.00 indicating that CorMedix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MediWound	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorMedix	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MDWD or CRMD more profitable?

CorMedix has a net margin of 0.00% compared to MediWound's net margin of -142.29%. CorMedix's return on equity of -79.21% beat MediWound's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediWound	-142.29%	-82.17%	-33.67%
CorMedix	N/A	-79.21%	-64.68%

Do analysts recommend MDWD or CRMD?

MediWound currently has a consensus price target of $29.75, indicating a potential upside of 42.55%. CorMedix has a consensus price target of $15.00, indicating a potential upside of 17.00%. Given MediWound's higher possible upside, analysts clearly believe MediWound is more favorable than CorMedix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
CorMedix	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Summary

CorMedix beats MediWound on 11 of the 19 factors compared between the two stocks.